LuCE aims to raise awareness about inequities regarding the access to lung cancer treatment and care in Europe. Moreover, it advocates European policies that will lead to improvements in lung cancer prevention, early detection, treatment and care.
Lung Cancer Europe provides a European platform for national lung cancer patient advocacy groups and supports the establishment of those groups in countries where such groups do not yet exist. Our member organisations and associate members come from all over Europe.
Lung cancer is literally the biggest cancer killer worldwide – causing more deaths than breast and prostate cancer put together all over the world. Read more about our diagnosis, types and stages of lung cancer, treatments and clinical trials, but also how to cope with lung cancer.
As part of its Educational & Capacity Building Programme, Lung Cancer Europe (LuCE) is running a 101 session on Policy & NGOs with the aim of learning the basics on influencing decision making in policy, regulatory and access frameworks at national and European level, as well as to explore the opportunities in which patient organisations can take part in those […]
Investing in the future: Improving cancer biomarker testing and cancer diagnosis for sustainable healthcare is a new white paper co-authored by a team of medical and patient advocacy experts, including representatives from the ECPC, Oncohealth Institute and Fight Bladder Cancer. The white paper calls for increased access to cancer biomarker testing, to identify those who will benefit most from precision […]
Since its establishment, LuCE has continually developed a range of reports tackling relevant challenges for the lung cancer community, such as access to treatment, care and testing, as well as issues around clinical trials in Europe. LuCE plans to develop a report on “Living with lung cancer: survivorship and quality of life” to explore how patients´ and caregivers´ lives have […]
Lung Cancer Europe (LuCE) held a webinar on current research lines in lung cancer. The webinar was given by Professor Simon Ekman, Senior Consultant and Associate Professor in Oncology at Karolinska University Hospital in Stockholm in Sweden. The webinar was held and recorded on 29th April 2021.
